Symbolbild · KI-generiert
Aclaris Therapeutics, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Aclaris Therapeutics is a pharmaceutical company focused on developing therapeutics for dermatological and immunological conditions. Its pipeline includes compounds for the treatment of alopecia and inflammatory diseases, among others.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Aclaris Therapeutics, Inc. | ACRS | NASDAQ | 726 Mio. USD |
| Monopar Therapeutics Inc. | MNPR | NASDAQ | 726 Mio. USD |
| Aura Biosciences, Inc. | AURA | NASDAQ | 725 Mio. USD |
| Candel Therapeutics, Inc. | CADL | NASDAQ | 733 Mio. USD |
| Bright Minds Biosciences Inc. | DRUG | CSE | 715 Mio. USD |
| Pharming Group N.V. ADS, each representing 10 ordinary shares | PHAR | NASDAQ | 712 Mio. USD |
| Faeth Therapeutics, Inc. | FTH | NASDAQ | 702 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.